PROGNOSTIC VALUES OF TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, INTERFERON-ALPHA, AND INTERFERON-GAMMA IN THE SERUM OF PATIENTS WITH SEPTIC SHOCK

被引:506
作者
CALANDRA, T
BAUMGARTNER, JD
GRAU, GE
WU, MM
LAMBERT, PH
SCHELLEKENS, J
VERHOEF, J
GLAUSER, MP
机构
[1] UNIV GENEVA,WHO IMUNOL RES & TRAINING CTR,CH-1211 GENEVA 4,SWITZERLAND
[2] STATE UNIV UTRECHT,CLIN BACTERIOL,UTRECHT,NETHERLANDS
关键词
D O I
10.1093/infdis/161.5.982
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serum concentrations of immunoreactive tumor necrosis factor/cachectin (TNF), interleukin-1β (IL-1β), interferon-γ (IFNγ), and interferon-α (IFNα) were prospectively measured in 70 patients with septic shock to determine their evolution and prognostic values. In a univariate analysis, levels of TNF (P = .002) and IL-1β (P = .05) were associated with the patient's outcome, but not IFNα (P = .15) and IFNγ (P = .26). In contrast, in a stepwise logistic regression analysis, the severity of the underlying disease (P = .01), the age of the patient (P = .02), the documentation of infection (nonbacteremic infections vs. bacteremias, P = .03), the urine output (P = .04), and the arterial pH (P = .05) contributed more significantly to prediction of patient outcome than the serum levels of TNF (P = .07). After 10 days, the median concentration of TNF was undetectable (<100 pg/ml) in the survivors, whereas it remained elevated (305 pg/ml, P = .002) in the nonsurvivors. Thus, in patients with septic shock due to various gram-negative bacteria, other parameters than the absolute serum concentration of immunoreactive TNF contributed significantly to the prediction of outcome.
引用
收藏
页码:982 / 987
页数:6
相关论文
共 25 条
[1]   PURIFICATION OF CACHECTIN, A LIPOPROTEIN-LIPASE SUPPRESSING HORMONE SECRETED BY ENDOTOXIN-INDUCED RAW 264.7 CELLS [J].
BEUTLER, B ;
MAHONEY, J ;
LETRANG, N ;
PEKALA, P ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :984-995
[2]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[3]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[4]  
BEUTLER BA, 1985, J IMMUNOL, V135, P3972
[5]  
BRYAN CS, 1983, REV INFECT DIS, V5, P629
[6]   TREATMENT OF GRAM-NEGATIVE SEPTIC SHOCK WITH HUMAN-IGG ANTIBODY TO ESCHERICHIA-COLI J5 - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED TRIAL [J].
CALANDRA, T ;
GLAUSER, MP ;
SCHELLEKENS, J ;
VERHOEF, J .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) :312-319
[7]   PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS [J].
DEBETS, JMH ;
KAMPMEIJER, R ;
VANDERLINDEN, MPMH ;
BUURMAN, WA ;
VANDERLINDEN, CJ .
CRITICAL CARE MEDICINE, 1989, 17 (06) :489-494
[8]   PLASMA TUMOR NECROSIS FACTOR LEVELS IN PATIENTS WITH PRESUMED SEPSIS - RESULTS IN THOSE TREATED WITH ANTILIPID-A ANTIBODY VS PLACEBO [J].
DEGROOTE, MA ;
MARTIN, MA ;
DENSEN, P ;
PFALLER, MA ;
WENZEL, RP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (02) :249-251
[9]   TUMOR-NECROSIS-FACTOR (CACHECTIN) IS AN ENDOGENOUS PYROGEN AND INDUCES PRODUCTION OF INTERLEUKIN-1 [J].
DINARELLO, CA ;
CANNON, JG ;
WOLFF, SM ;
BERNHEIM, HA ;
BEUTLER, B ;
CERAMI, A ;
FIGARI, IS ;
PALLADINO, MA ;
OCONNOR, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) :1433-1450
[10]  
DINARELLO CA, 1988, REV INFECT DIS, V10, P168